Pharmaceutical Product Monograph: Aceclofenac Injection (150 mg/1 mL or 150 mg/3 mL)
In the pharmaceutical industry, Aceclofenac is a potent Non-Steroidal Anti-Inflammatory Drug (NSAID) of the phenylacetic acid class. As a pharmacist and manufacturer, I view this molecule as a “Preferential COX-2 Inhibitor”—it is technically designed to provide powerful analgesia with a slightly better gastric safety profile than older NSAIDs like Diclofenac.
At your WHO-GMP facility in Mumbai, Aceclofenac injection is a critical SKU for the Institutional and Hospital supply segments, where rapid onset of action is required for acute, debilitating painTherapeutic Profile: Primary Indications
Aceclofenac injection is indicated for the short-term management of acute, severe pain and inflammation when oral therapy is not feasible.
| Indication | Clinical Context | Technical Rationale |
| Post-Operative Pain | Surgical Recovery | Rapidly reduces prostaglandin synthesis at the surgical site to manage moderate-to-severe pain. |
| Acute Renal Colic | Emergency Care | Highly effective in relaxing the smooth muscle spasms associated with kidney stones. |
| Severe Osteoarthritis | Acute Flare-ups | Provides immediate relief from joint inflammation and “morning stiffness.” |
| Ankylosing Spondylitis | Chronic Management | Targets spinal inflammation to improve mobility during acute episodes. |
| Low Back Pain | Acute Trauma | Used for severe lumbago or sciatica where the patient cannot swallow or needs fast relief. |
Mechanism: COX Inhibition & Cytokine Modulation
Aceclofenac works through a sophisticated multi-pathway approach to “shut down” the pain signal:
Preferential COX-2 Inhibition: It inhibits the enzyme Cyclooxygenase-2 (COX-2), which is responsible for producing the prostaglandins that cause pain and swelling.
Cytokine Suppression: Technically, Aceclofenac is unique because it also inhibits the synthesis of pro-inflammatory cytokines like IL-1$\beta$ and TNF, which are the primary drivers of joint destruction in arthritis.
Glycosaminoglycan Synthesis: Unlike some NSAIDs that can damage joint cartilage, studies suggest Aceclofenac may actually stimulate the synthesis of the “building blocks” of cartilage (proteoglycans).
The Pharmacist’s “Technical Warning”
The “IM Only” Rule: As a pharmacist, I must emphasize that most Aceclofenac injections are for Deep Intramuscular (IM) use only. Intravenous (IV) administration is generally contraindicated unless a specific IV-compatible formulation is used.
The “Renal” Risk: Like all NSAIDs, it can reduce blood flow to the kidneys. It must be used with extreme caution in dehydrated patients or those with existing kidney impairment.
Cardiovascular Note: Long-term use or high-dose injections are associated with a slight increase in thrombotic events (heart attack/stroke). It is technically contraindicated in patients with established ischemic heart disease.
Asthma Interaction: “Aspirin-sensitive” asthmatics are at high risk of developing bronchospasm when given Aceclofenac.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Solubility & pH” USP: On your digital marketplace, highlight your Advanced Solubilization Technology. Aceclofenac is poorly soluble in water; your WHO-GMP process ensures a stable, clear solution with optimal pH to minimize “injection site pain” for the patient.
Preservative-Free Options: For premium export markets, offering Single-dose Ampoules that are preservative-free is a major technical advantage for B2B hospital tenders.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Aceclofenac 150 mg/mL injections to support your registration in international tenders for pain management and orthopedics.